XHE SPDR S&P Health Care Equipment ETF
- Health & Biotech Equities
XHE - Profile
- Issuer: State Street SPDR
- Structure: ETF
- Expense Ratio: 0.35%
- ETF Home Page: XHE
- Inception: Jan 26, 2011
- Tax Form: 1099
- XHE Tracks This Index: S&P Health Care Equipment Select Industry Index
- 52 Week Lo: $73.65
- 52 Week Hi: $99.61
- AUM: $53.2 M
- Shares: 0.6 M
Alternative ETFs in the Health & Biotech Equities Category
|Type||Ticker||Expense Ratio||Assets||Avg. Daily Vol||YTD Return|
|Most Liquid (Volume)|
|Top YTD Performer|
The index represents the health care equipment and supplies sub-industry portion of the S&P Total Stock Market Index.
XHE - Realtime Rating
Realtime Rating Summary
XHE is a passive ETF that seeks to replicate S&P Health Care Equipment Select Industry Index. The index represents the health care equipment and supplies sub-industry portion of the S&P Total Stock Market Index.
The adjacent table gives investors an individual Realtime Rating for XHE on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.
XHE In-Depth Analysis
The following tables and charts contain in-depth metrics for XHE and compare it to similar peer ETFs within its ETFdb Category.
XHE - HoldingsFilings Data as of: Jul 05, 2015
Top Ten Holdings
This section compares how balanced and deep XHE is relative to the peer group ETFdb Category.
XHE Asset Allocation
XHE Sector Breakdown
XHE Market Cap Breakdown
XHE Region Breakdown
XHE Market Tier Breakdown
XHE Country Breakdown
XHE - Expenses & Fees
This section compares the cost efficiency of XHE to peers in the same ETFdb Category.
Expenses Ratio Analysis
Commission Free Trading in XHE
XHE is not currently available for commission free trading on any platforms.
Category Commission Free Trading
There are 3 other ETFs in the Health & Biotech Equities ETFdb Category that are also eligible for commission free trading:
XHE - Performance
This section shows how XHE has performed relative to its peer group ETFdb Category.
XHE - Charts
The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.
The following chart also includes the option to compare the performance of XHE relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.
XHE - Technicals
XHE Volatility Analysis
This section shows how the volatility of XHE compares to the peer group ETFdb Category.
- 20 Day MA: $95.84
- 60 Day MA: $94.31
- MACD 15 Period: 0.32
- MACD 100 Period: 2.61
- Williams % Range 10 Day: 66.26
- Williams % Range 20 Day: 37.36
- RSI 10 Day: 54
- RSI 20 Day: 55
- RSI 30 Day: 55
- Ultimate Oscillator: 56
XHE Bollinger Bands
- Lower Bollinger (10 Day): $95.32
- Upper Bollinger (10 Day): $99.18
- Lower Bollinger (20 Day): $92.18
- Upper Bollinger (20 Day): $99.45
- Lower Bollinger (30 Day): $92.70
- Upper Bollinger (30 Day): $98.92
XHE Support & Resistance
- Support Level 1: $96.82
- Support Level 2: $96.73
- Resistance Level 1: $97.04
- Resistance Level 2: $97.17
- Stochastic Oscillator %D (1 Day): 48.30
- Stochastic Oscillator %D (5 Day): 35.81
- Stochastic Oscillator %K (1 Day): 51.65
- Stochastic Oscillator %K (5 Day): 49.25
Latest XHE News
Healthcare ETFs: 4 Things To Consider
Obama Victory Puts Healthcare ETFs In Focus
Forget AAPL, Find Some ISRG
2014 Morningstar, Inc. All Rights Reserved. The information contained herein: ( 1 ) is proprietary to Morningstar and/or its content providers; ( 2 ) may not be copied or distributed; and ( 3 ) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.